{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:56:51Z","timestamp":1791921411719,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.biologicals.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T03:10:07Z","timestamp":1558062607000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA"],"prefix":"10.1016","volume":"60","author":[{"given":"Audrey","family":"Toinon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadege","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloise","family":"Chausse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Claire","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Guinchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jaudinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Guinet-Morlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Manin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2019.05.004_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(04)15792-9","article-title":"Rabies and other lyssavirus diseases","volume":"363","author":"Warrell","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2019.05.004_bib2","series-title":"Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs","year":"2007"},{"key":"10.1016\/j.biologicals.2019.05.004_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.004_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.provac.2011.10.004","article-title":"Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions","volume":"5","author":"Isbrucker","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.05.004_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.1996.0012","article-title":"Use of ELISA for in vitro potency test of rabies vaccines for animal use","volume":"24","author":"Gamoh","year":"1996","journal-title":"Biologicals : J Int Assoc Buddh Stud"},{"key":"10.1016\/j.biologicals.2019.05.004_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.1998.tb02270.x","article-title":"Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies","volume":"42","author":"Luo","year":"1998","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.05.004_bib10","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1016\/j.vaccine.2013.10.019","article-title":"A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release","volume":"31","author":"Gibert","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.004_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0264-410X(85)90224-5","article-title":"Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies","volume":"3","author":"Perrin","year":"1985","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.004_bib13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2016.12.039","article-title":"Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - results of an international collaborative study","volume":"35","author":"Morgeaux","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.004_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(11)60478-9","article-title":"Vaccine production, distribution, access, and uptake","volume":"378","author":"Smith","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2019.05.004_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-1157(85)80042-1","article-title":"Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay","volume":"13","author":"Lafon","year":"1985","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2019.05.004_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0092-1157(77)80009-7","article-title":"A comparison of the Pasteur and Pitman-Moore strains of rabies virus for the production of rabies vaccine in human diploid cells","volume":"5","author":"Majer","year":"1977","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2019.05.004_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies","volume":"84","author":"Schumacher","year":"1989","journal-title":"J Clin Investig"},{"key":"10.1016\/j.biologicals.2019.05.004_bib18","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"Muller","year":"2009","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.biologicals.2019.05.004_bib19","series-title":"Protein biotinylation. Current protocols in protein science\/editorial board","author":"Elia","year":"2010"},{"key":"10.1016\/j.biologicals.2019.05.004_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2019.05.004_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/09296174.2013.799918","article-title":"Binomial confidence intervals and contingency tests: mathematical fundamentals and the evaluation of alternative methods","volume":"20","author":"Wallis","year":"2013","journal-title":"J Quant Linguist"},{"key":"10.1016\/j.biologicals.2019.05.004_bib22","first-page":"329","article-title":"Study of rabies virus by differential scanning calorimetry","volume":"4","author":"Toinon","year":"2015","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.biologicals.2019.05.004_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","article-title":"Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G","volume":"73","author":"Mebatsion","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsb.2011.07.003","article-title":"Three dimensional morphology of rabies virus studied by cryo-electron tomography","volume":"176","author":"Guichard","year":"2011","journal-title":"J Struct Biol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/bj1060829","article-title":"Reaction of beta-propiolactone with amino acids and its specificity for methionine","volume":"106","author":"Taubman","year":"1968","journal-title":"Biochem J"},{"key":"10.1016\/j.biologicals.2019.05.004_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2012.09.008","article-title":"Differential scanning calorimetry as a tool for protein folding and stability","volume":"531","author":"Johnson","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biologicals.2019.05.004_bib27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1042\/bj20020290","article-title":"Thermal denaturation of influenza virus and its relationship to membrane fusion","volume":"365","author":"Epand","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.biologicals.2019.05.004_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/BA20040113","article-title":"Characterization of different strains of poliovirus and influenza virus by differential scanning calorimetry","volume":"41","author":"Krell","year":"2005","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.biologicals.2019.05.004_bib29","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.vaccine.2009.12.006","article-title":"Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?","volume":"28","author":"Poirier","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.004_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.8.3.313","article-title":"Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement","volume":"8","author":"Hendriksen","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2019.05.004_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0006-2952(65)90040-7","article-title":"Studies of the reaction of beta-propiolactone with deoxyguanosine and related compounds","volume":"14","author":"Colburn","year":"1965","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0006-2952(63)90216-8","article-title":"The reaction of beta-propiolactone with guanosine, deoxyguanylic acid and RNA","volume":"12","author":"Roberts","year":"1963","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00038-17","article-title":"Beta-propiolactone inactivation of coxsackievirus A16 induces structural alteration and surface modification of viral capsids","volume":"91","author":"Fan","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2019.05.004_bib34","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/pmic.201300096","article-title":"Surface modifications of influenza proteins upon virus inactivation by beta-propiolactone","volume":"13","author":"She","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.biologicals.2019.05.004_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbamem.2013.09.021","article-title":"Treatment of influenza virus with beta-propiolactone alters viral membrane fusion","volume":"1838","author":"Bonnafous","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2019.05.004_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0264-410X(93)90343-V","article-title":"Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus","volume":"11","author":"Morgeaux","year":"1993","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618303282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618303282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:18Z","timestamp":1760922798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618303282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"alternative-id":["S1045105618303282"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.05.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}